Abstract
A synthetic route toward new 1-alkyl-3-aminomethyl-3-fluoropiperidines,
which are of high interest as building blocks in medicinal chemistry,
is described. The successful approach consists of the fluorination
of ethyl 3-chloropropyl-2-cyanoacetate with N -fluorodibenzenesulfonimide
(NFSI) and transformation of the ester moiety into different amides,
yielding N -alkyl-5-chloro-2-cyano-2-fluoropentanamides.
Ring closure was achieved under basic conditions, yielding 1-alkyl-3-fluoro-2-oxopiperidine-3-carbonitriles.
After
reduction of the obtained lactams with borane, the desired 3-aminomethyl-3-fluoropiperidines
were obtained in good yields.
Key words
ring closure - NFSI - 3-fluoropiperidines - fluorine chemistry - heterocycles
References and Notes <A NAME="RG08009ST-1">1 </A>
Postdoctoral Fellow of the Research
Foundation - Flanders (FWO-Vlaanderen)
For examples, see:
<A NAME="RG08009ST-2A">2a </A>
Papeo GME,
Caronni D,
Dalvit C,
Giordano P,
Mongelli N,
Veronesi M, and
Ciprandi F. inventors; Eur. Pat. Appl. EP 1923397.
;
A1 20080521
<A NAME="RG08009ST-2B">2b </A>
Grabstein KH,
Wang A,
Nairn N,
Winblade G, and
Thomas J. inventors; U.S.
Pat. Appl. Publ. US 2008096819.
; A1
20080424
<A NAME="RG08009ST-2C">2c </A>
Edmondson SD.
Mastracchio A.
Mathvink RJ.
He J.
Harper B.
Park Y.-J.
Beconi M.
Di Salvo J.
Eiermann GJ.
He H.
Leiting B.
Leone
JF.
Levorse DA.
Lyons K.
Patel RA.
Patel SB.
Petrov A.
Scapin G.
Shang J.
Roy RS.
Smith A.
Wu JK.
Xu S.
Zhu B.
Thornberry NA.
Weber AE.
J.
Med. Chem.
2006,
49:
3614
<A NAME="RG08009ST-2D">2d </A>
Celanire S,
Quere L,
Denonne F, and
Provins L. inventors; PCT Int. Appl. WO 2007048595.
;
A1 20070503
<A NAME="RG08009ST-2E">2e </A>
Keith JM.
Gomez LA.
Letavic MA.
Ly KS.
Jablonowski JA.
Seierstad M.
Barbier AJ.
Wilson SJ.
Boggs JD.
Fraser IC.
Mazur C.
Lovenberg TW.
Carruthers NI.
Bioorg.
Med. Chem. Lett.
2007,
17:
702
<A NAME="RG08009ST-2F">2f </A>
Parker JC, and
Hulin B. inventors; US Pat.
Appl. Publ. US 2005043292.
;
A1 24/02/2005; Chem. Abstr. 2005 , 142 , 261783
<A NAME="RG08009ST-3A">3a </A>
Fluorine
in Bioorganic Chemistry
Welch JT.
Eswarakrishnan S.
Wiley-Interscience;
New
York:
1991.
<A NAME="RG08009ST-3B">3b </A>
Bioorganic and
Medicinal Chemistry of Fluorine
Bégué JP.
Bonnet-Delpon D.
John
Wiley & Sons, Inc.;
New Jersey:
2008.
<A NAME="RG08009ST-4">4 </A>
Hagmann WK.
J.
Med. Chem.
2008,
51:
4359
<A NAME="RG08009ST-5">5 </A>
O" Hagan D.
Chem.
Soc. Rev.
2008,
37:
308
<A NAME="RG08009ST-6">6 </A>
Purser S.
Moore PR.
Swallow S.
Gouverneur V.
Chem. Soc. Rev.
2008,
37:
320
<A NAME="RG08009ST-7">7 </A>
Kirk KL.
Org.
Process Res. Dev.
2008,
12:
305
<A NAME="RG08009ST-8">8 </A>
Müller K.
Faeh C.
Diederich F.
Science
2007,
317:
1881
<A NAME="RG08009ST-9">9 </A>
Differding E.
Frick W.
Lang RW.
Martin P.
Schmit C.
Veenstra S.
Greuter H.
Bull.
Soc. Chim. Belg.
1990,
99:
647
<A NAME="RG08009ST-10">10 </A> inventors; Barrow J. C., Lindsley
C. W., Shipe W. D., Yang Z.: PCT Int. Appl. WO/2007/002361.
; Chem. Abstr. 2007 , 146 , 121830
<A NAME="RG08009ST-11">11 </A>
Verniest G.
Surmont R.
Van Hende E.
Deweweire A.
Deroose F.
Thuring JW.
De Kimpe N.
J.
Org. Chem.
2008,
73:
5458
<A NAME="RG08009ST-12">12 </A>
Van Niel MB.
Collins I.
Beer MS.
Broughton HB.
Cheng SKF.
Goodacre SC.
Heald A.
Locker KL.
MacLeod AM.
Morrison D.
J.
Med. Chem.
1999,
42:
2087
<A NAME="RG08009ST-13">13 </A>
Sun A.
Lankin DC.
Hardcastle K.
Snyder JP.
Chem. Eur. J.
2005,
11:
1579
<A NAME="RG08009ST-14">14 </A>
Dechamps I.
Gomez Pardo D.
Cossy J.
Eur.
J. Org. Chem.
2007,
4224
<A NAME="RG08009ST-15A">15a </A>
Ono N.
Yoshimura T.
Saito T.
Tamura R.
Tanikaga R.
Kaji A.
Bull. Chem.
Soc. Jpn.
1979,
52:
1716
<A NAME="RG08009ST-15B">15b </A>
Muthusamy S.
Gnanaprakasam B.
Tetrahedron Lett.
2005,
46:
635
<A NAME="RG08009ST-16">16 </A>
Zefirov NS.
Kuznetsova TS.
Kozhushkov SI.
Surmina LS.
Rashchupkina ZA.
Zh. Org. Khim.
1983,
19:
541
<A NAME="RG08009ST-17">17 </A>
Grossman RB.
Varner MA.
J. Org. Chem.
1997,
62:
5235